Company page

Spruce Biosciences, Inc.

Spruce Biosciences, Inc. (ticker: SPRB) is a public company based in the United States, specializing in the development of innovative therapies for rare endocrine disorders. With a market capitalization of approximately $142.8 million, Spruce is focused on advancing its pipeline to address unmet medical needs in this niche area. The company is committed to improving patient outcomes through its research and development efforts.